Abbott Receives FDA Clearance for Leukemia Diagnostic Test
Abbott has received 510(k) clearance from the FDA for a new in vitro diagnostic test to aid in determining the prognosis of patients with acute myeloid leukemia
Read MorePosted by Clinical Lab Products | Oct 26, 2011 | Cancer, Miscellaneous |
Abbott has received 510(k) clearance from the FDA for a new in vitro diagnostic test to aid in determining the prognosis of patients with acute myeloid leukemia
Read MorePosted by Clinical Lab Products | Sep 23, 2011 | Miscellaneous |
A study supported by HHS could not validate or confirm previous research findings that suggested the presence of one of several viruses in blood samples of people living with chronic fatigue syndrome.
Read MorePosted by Clinical Lab Products | Sep 1, 2011 | Molecular Diagnostics |
Molecular diagnostics has advanced in precision, accuracy, speed, and detection. There is much to commend, and much is to be done promising exciting health care solutions.
Read MorePosted by Clinical Lab Products | May 27, 2011 | Cancer, Miscellaneous |
A company spokeswoman attributes the shortage to the company’s inability to meet increasing demand and the transition to a new plant for bottling and labeling operations.
Read MorePosted by Clinical Lab Products | May 1, 2011 | Cancer, Miscellaneous |
BioCare Medical LLC offers a new look at prostate cancer diagnosis.
Read More